All companies, by operating profit growth
505 companies and 2079 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Op. profit Y/Y | Quarter |
|---|---|---|---|---|---|
| 176 |
|
$12.9B | $152.28 −0.9% | +16% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 ALLE Allegion |
| 177 |
|
$72.7B | $275.28 −0.3% | +16% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 CI Cigna |
| 178 |
|
$16.6B | $55.00 −0.1% | +16% Year over yearQ1 FY26 against the same quarter a year earlier | Q1 FY26 FTV Fortive |
| 179 |
|
$186B | $150.11 −0.5% | +16% Year over yearQ1 FY26 against the same quarter a year earlier | Q1 FY26 GILD Gilead Sciences |
| 180 |
|
$11.7B | $185.78 −1.1% | +16% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 IT Gartner |
| 181 |
|
$20.0B | $205.04 −1.4% | +16% Year over yearQ1 FY27 against the same quarter a year earlier | Q1 FY27 STE Steris |
| 182 |
|
$18.4B | $79.78 −1.3% | +15% Year over yearQ1 FY26 against the same quarter a year earlier | Q1 FY26 EVRG Evergy |
| 183 |
|
$56.2B | $49.01 −0.3% | +15% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 FAST Fastenal |
| 184 |
|
$23.6B | $446.92 +0.8% | +15% Year over yearQ1 FY26 against the same quarter a year earlier | Q1 FY26 HUBB Hubbell Incorporated |
| 185 |
|
$46.0B | $247.29 −1.3% | +15% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 LHX L3Harris |
| 186 |
|
$40.2B | $552.87 +0.6% | +15% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 MSCI MSCI |
| 187 |
|
$54.5B | $237.64 +1.4% | +14% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 AME Ametek |
| 188 |
|
$11.8B | $22.80 −1.0% | +14% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 BAX Baxter International |
| 189 |
|
$40.3B | $511.65 +1.0% | +14% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 IDXX Idexx Laboratories |
| 190 |
|
$22.0B | $107.77 −0.5% | +14% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 L Loews |
| 191 |
|
$26.0B | $320.71 −0.6% | +14% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 LH Labcorp |
| 192 |
|
$59.5B | $205.42 −0.6% | +14% Year over yearQ3 FY26 against the same quarter a year earlier | Q3 FY26 TEL TE Connectivity |
| 193 |
|
$241B | $651.45 −1.0% | +14% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 TMO Thermo Fisher Scientific |
| 194 |
|
$13.3B | $173.42 +0.7% | +13% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 GL Globe Life |
| 195 |
|
$9.5B | $84.84 −0.2% | +13% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 HSIC Henry Schein |
| 196 |
|
$26.2B | $45.26 −1.0% | +12% Year over yearQ1 FY26 against the same quarter a year earlier | Q1 FY26 FE FirstEnergy |
| 197 |
|
$95.5B | $353.05 −0.8% | +12% Year over yearQ1 FY26 against the same quarter a year earlier | Q1 FY26 GD General Dynamics |
| 198 |
|
$13.1B | $48.72 −2.0% | +12% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 MKC McCormick & Company |
| 199 |
|
$8.4B | $81.68 −1.5% | +12% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 WYNN Wynn Resorts |
| 200 |
|
$126B | $167.90 −1.5% | +11% Year over yearQ2 FY26 against the same quarter a year earlier | Q2 FY26 BKNG Booking |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.